Cystatin C - And creatinine-based estimated glomerular filtration rate, vascular disease, and mortality in persons with diabetes in the U.S

Diabetes Care

Volumn 37, Issue 4, 2014, Pages 1002-1008

  Tsai, Ching Wei ^a   Grams, Morgan E ^b   Inker, Lesley A ^c   Coresh, Josef ^a,b   Selvin, Elizabeth ^a,b  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; CYSTATIN C;

ADULT; AGE; ALBUMINURIA; ARTICLE; BODY MASS; CARDIOVASCULAR MORTALITY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIABETIC RETINOPATHY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PREVALENCE; UNITED STATES; VASCULAR DISEASE; AGED; BLOOD; EPIDEMIOLOGY; MIDDLE AGED; NUTRITION; PATHOPHYSIOLOGY; RENAL INSUFFICIENCY, CHRONIC; VASCULAR DISEASES;

ADULT; AGED; CREATININE; CYSTATIN C; DIABETES COMPLICATIONS; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; MALE; MIDDLE AGED; NUTRITION SURVEYS; RENAL INSUFFICIENCY, CHRONIC; UNITED STATES; VASCULAR DISEASES;

EID: 84897910668     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc13-1910     Document Type: Article

References (36)

1. National Kidney Foundation. KDOQI clinical practice guideline for diabetes and CKD: 2012 update. Am J Kidney Dis 2012;60:850-886
2. U.S. Renal Data System. USRDS 2012 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2012
3. de Boer IH, Rue TC, Hall YN, Heagerty PJ, Weiss NS, Himmelfarb J. Temporal trends in the prevalence of diabetic kidney disease in the United States. JAMA 2011;305:2532-2539
4. Cowie CC, Rust KF, Byrd-Holt DD, et al. Prevalence of diabetes and high risk for diabetes using A1C criteria in the U.S. population in 1988-2006. Diabetes Care 2010;33:562-568
5. Goff DC Jr, Gerstein HC, Ginsberg HN, et al.; ACCORD Study Group. Prevention of cardiovascular disease in persons with type 2 diabetes mellitus: current knowledge and rationale for the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Am J Cardiol 2007;99:4i-20i
6. Tandon N, Ali MK, Narayan KM. Pharmacologic prevention of microvascular and macrovascular complications in diabetes mellitus: implications of the results of recent clinical trials in type 2 diabetes. Am J Cardiovasc Drugs 2012;12:7-22
7. Matsushita K, van der Velde M, Astor BC, et al.; Chronic Kidney Disease Prognosis Consortium. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet 2010;375:2073-2081
8. Fox CS, Matsushita K, Woodward M, et al.; Chronic Kidney Disease Prognosis Consortium. Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis. Lancet 2012;380:1662-1673
9. Ferguson MA, Waikar SS. Established and emerging markers of kidney function. Clin Chem 2012;58:680-689
10. Stevens LA, Coresh J, Schmid CH, et al. Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD. Am J Kidney Dis 2008;51:395-406 (Pubitemid 351273480)
11. Astor BC, Levey AS, Stevens LA, Van Lente F, Selvin E, Coresh J. Method of glomerular filtration rate estimation affects prediction of mortality risk. J Am Soc Nephrol 2009;20:2214-2222
12. Shlipak MG, Wassel Fyr CL, Chertow GM, et al. Cystatin C and mortality risk in the elderly: the health, aging, and body composition study. J Am Soc Nephrol 2006;17:254-261
13. Stevens LA, Schmid CH, Greene T, et al. Factors other than glomerular filtration rate affect serum cystatin C levels. Kidney Int 2009;75:652-660
14. Iliadis F, Didangelos T, Ntemka A, et al. Glomerular filtration rate estimation in patients with type 2 diabetes: creatinine- or cystatin C-based equations? Diabetologia 2011;54:2987-2994
15. Silveiro SP, Araújo GN, Ferreira MN, Souza FD, Yamaguchi HM, Camargo EG. Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation pronouncedly underestimates glomerular filtration rate in type 2 diabetes. Diabetes Care 2011;34:2353-2355
16. Inker LA, Schmid CH, Tighiouart H, et al.; CKD-EPI Investigators. Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med 2012;367:20-29
17. Levey AS, Stevens LA, Schmid CH, et al.; CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med 2009;150:604-612
18. Köttgen A, Selvin E, Stevens LA, Levey AS, Van Lente F, Coresh J. Serum cystatin C in the united states: The third national health and nutrition examination survey (NHANES III). Am J Kidney Dis 2008;51:385-394 (Pubitemid 351273481)
19. Centers for Disease Control and Prevention (CDC). Survey operations manuals, brochures, and consent documents: 1999-2000 NHANES. Lower extremity disease procedures manual [Internet], 2001. Available from http://www.cdc.gov/ nchs/data/nhanes/le.pdf. Accessed 28 April 2013
20. Feringa HH, Bax JJ, van Waning VH, et al. The long-term prognostic value of the resting and postexercise ankle-brachial index. Arch Intern Med 2006;166:529-535
21. Selvin E, Manzi J, Stevens LA, et al. Calibration of serum creatinine in the national health and nutrition examination surveys (NHANES) 1988-1994, 1999-2004. Am J Kidney Dis 2007;50:918-926 (Pubitemid 350122815)
22. Selvin E, Juraschek SP, Eckfeldt J, Levey AS, Inker LA, Coresh J. Calibration of cystatin C in the National Health and Nutrition Examination Surveys (NHANES). Am J Kidney Dis 2013;62:253-260
23. Newman AB, Siscovick DS, Manolio TA, et al.; Cardiovascular Heart Study (CHS) Collaborative Research Group. Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Circulation 1993;88:837-845 (Pubitemid 23263998)
24. NHANES (1999-2004) public use linked mortality files [article online]. Available from http://www.cdc.gov/nchs/data-access/data-linkage/mortality/ nhanes-99-04-linkage.htm#description. Accessed 31 July 2013
25. Zou G. A modified poisson regression approach to prospective studies with binary data. Am J Epidemiol 2004;159:702-706 (Pubitemid 38405384)
26. Grams ME, Juraschek SP, Selvin E, et al. Trends in the prevalence of reduced GFR in the United States: a comparison of creatinine- and cystatin C-based estimates. Am J Kidney Dis 2013;62:253-260
27. Rule AD, Bailey KR, Lieske JC, Peyser PA, Turner ST. Estimating the glomerular filtration rate from serum creatinine is better than from cystatin C for evaluating risk factors associated with chronic kidney disease. Kidney Int 2013;83:1169-1176
28. Pattaro C, Riegler P, Stifter G, Modenese M, Minelli C, Pramstaller PP. Estimating the glomerular filtration rate in the general population using different equations: effects on classification and association. Nephron Clin Pract 2013;123:102-111
29. Gaspari F, Ruggenenti P, Porrini E, et al.; GFR Study Investigators. The GFR and GFR decline cannot be accurately estimated in type 2 diabetics. Kidney Int 2013;84:164-173
30. Rossing P, Rossing K, Gaede P, Pedersen O, Parving HH. Monitoring kidney function in type 2 diabetic patients with incipient and overt diabetic nephropathy. Diabetes Care 2006;29:1024-1030 (Pubitemid 44115239)
31. Chew-Harris JS, Florkowski CM, George PM, Elmslie JL, Endre ZH. The relative effects of fat versus muscle mass on cystatin C and estimates of renal function in healthy young men. Ann Clin Biochem 2013;50:39-46
32. Knight EL, Verhave JC, Spiegelman D, et al. Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. Kidney Int 2004;65:1416-1421 (Pubitemid 38406982)
33. Macdonald J, Marcora S, Jibani M, et al. GFR estimation using cystatin C is not independent of body composition. Am J Kidney Dis 2006;48:712-719 (Pubitemid 44740040)
34. Wolf G, Müller N, Mandecka A, Müller UA. Association of diabetic retinopathy and renal function in patients with types 1 and 2 diabetes mellitus. Clin Nephrol 2007;68:81-86 (Pubitemid 47243952)
35. Menon V, Shlipak MG, Wang X, et al. Cystatin C as a risk factor for outcomes in chronic kidney disease. Ann Intern Med 2007;147:19-27
36. de Boer IH, Katz R, Cao JJ, et al. Cystatin C, albuminuria, and mortality among older adults with diabetes. Diabetes Care 2009;32:1833-1838